EPICYPHER
Durham, North Carolina, United States · Biotechnology · 50 employees
A pioneer in the field of epigenetics and chromatin biology, EpiCypher is a bioscience company developing transformative technologies and delivering superior products to researchers world-wide. Our technologies and products are making studies possible that were not imaginable just a few years ago. Our renowned chromatin researchers possess expertise and unique insight into chromatin biology an
Funding history
- Grant — $1.0M — Jun 2026
- Venture - Series Unknown — $3.3M — Jul 2024
Recent signals
- Jun 26, 2026: Raised $1.0M in Grant
- Jul 11, 2024: Raised $3.3M in Venture - Series Unknown
See plans & pricing → Track EPICYPHER’s funding, hiring, and signals — with verified contacts — on Fundz.